PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+16.96%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$116M
AUM Growth
+$116M
(+20%)
Cap. Flow
+$28.5M
Cap. Flow
% of AUM
24.54%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
KALA BIO
KALA
|
$43.2M |
Top Sells
| 1 |
Dare Bioscience
DARE
|
$9.23M |
| 2 |
Cartesian Therapeutics
RNAC
|
$5.41M |
Sector Composition
| 1 | Healthcare | 93.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
KALA BIO
KALA
$78.8M
| $43.2M | 37.13% | +1,890,913 | New | +$43.2M |
|
|
2
Cartesian Therapeutics
RNAC
$261M
| $29.7M | 25.53% | 1,627,527 -296,624 | -15% | -$5.41M |
|
3
Fate Therapeutics
FATE
$120M
| $9.79M | 8.42% | 2,473,186 | – | – |
|
|
ATYR
4
aTyr Pharma
ATYR
$527M
| $9.23M | 7.94% | 1,827,992 | – | – |
|
|
TTOO
5
DELISTED
T2 Biosystems, Inc
TTOO
| $7.88M | 6.77% | 1,875,524 | – | – |
|
6
Pulmatrix
PULM
$18M
| $7.4M | 6.36% | 3,607,996 | – | – |
|
|
TRVN
7
DELISTED
Trevena, Inc.
TRVN
| $5.24M | 4.5% | 2,053,540 | – | – |
|
|
GNCA
8
DELISTED
Genocea Biosciences, Inc.
GNCA
| $2.87M | 2.47% | 1,968,606 | – | – |
|
|
9
Dare Bioscience
DARE
$27.2M
| $1.03M | 0.88% | 328,752 -2,958,777 | -90% | -$9.23M |
|